These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36592307)

  • 1. Base Editing of Human Hematopoietic Stem Cells.
    Zeng J; Casirati G; Nguyen MA; Genovese P; Bauer DE
    Methods Mol Biol; 2023; 2606():43-62. PubMed ID: 36592307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic base editing of human hematopoietic stem cells.
    Zeng J; Wu Y; Ren C; Bonanno J; Shen AH; Shea D; Gehrke JM; Clement K; Luk K; Yao Q; Kim R; Wolfe SA; Manis JP; Pinello L; Joung JK; Bauer DE
    Nat Med; 2020 Apr; 26(4):535-541. PubMed ID: 32284612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models.
    Demirci S; Khan MBN; Hinojosa G; Le A; Leonard A; Essawi K; Gudmundsdottir B; Liu X; Zeng J; Inam Z; Chu R; Uchida N; Araki D; London E; Butt H; Maitland SA; Bauer DE; Wolfe SA; Larochelle A; Tisdale JF
    Cytotherapy; 2024 Jun; 26(6):641-648. PubMed ID: 38506770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Base editing of haematopoietic stem cells rescues sickle cell disease in mice.
    Newby GA; Yen JS; Woodard KJ; Mayuranathan T; Lazzarotto CR; Li Y; Sheppard-Tillman H; Porter SN; Yao Y; Mayberry K; Everette KA; Jang Y; Podracky CJ; Thaman E; Lechauve C; Sharma A; Henderson JM; Richter MF; Zhao KT; Miller SM; Wang T; Koblan LW; McCaffrey AP; Tisdale JF; Kalfa TA; Pruett-Miller SM; Tsai SQ; Weiss MJ; Liu DR
    Nature; 2021 Jul; 595(7866):295-302. PubMed ID: 34079130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified CD34+ hematopoietic stem and progenitor cell isolation strategy from cryopreserved human umbilical cord blood.
    Mata MF; Hernandez D; Rologi E; Grandolfo D; Hassan E; Hua P; Kallmeier R; Hirani S; Heuts F; Tittrea V; Choo Y; Baradez MO; Watt SM; Tarunina M
    Transfusion; 2019 Dec; 59(12):3560-3569. PubMed ID: 31769050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic gene editing in CD34
    Diez B; Genovese P; Roman-Rodriguez FJ; Alvarez L; Schiroli G; Ugalde L; Rodriguez-Perales S; Sevilla J; Diaz de Heredia C; Holmes MC; Lombardo A; Naldini L; Bueren JA; Rio P
    EMBO Mol Med; 2017 Nov; 9(11):1574-1588. PubMed ID: 28899930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic adenine base editing of human hematopoietic stem cells.
    Liao J; Chen S; Hsiao S; Jiang Y; Yang Y; Zhang Y; Wang X; Lai Y; Bauer DE; Wu Y
    Nat Commun; 2023 Jan; 14(1):207. PubMed ID: 36639729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.
    Yudovich D; Bäckström A; Schmiderer L; Žemaitis K; Subramaniam A; Larsson J
    Sci Rep; 2020 Dec; 10(1):22393. PubMed ID: 33372184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CCR5 Gene Edited CD34
    Karuppusamy KV; Demosthenes JP; Venkatesan V; Christopher AC; Babu P; Azhagiri MK; Jacob A; Ramalingam VV; Rangaraj S; Murugesan MK; Marepally SK; Varghese GM; Srivastava A; Kannangai R; Thangavel S
    Front Immunol; 2022; 13():792684. PubMed ID: 35359982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells.
    El-Kharrag R; Berckmueller KE; Madhu R; Cui M; Campoy G; Mack HM; Wolf CB; Perez AM; Humbert O; Kiem HP; Radtke S
    Mol Ther; 2022 Jun; 30(6):2186-2198. PubMed ID: 35240320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates.
    Gori JL; Butler JM; Kunar B; Poulos MG; Ginsberg M; Nolan DJ; Norgaard ZK; Adair JE; Rafii S; Kiem HP
    Stem Cells Transl Med; 2017 Mar; 6(3):864-876. PubMed ID: 28297579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34
    Cromer MK; Vaidyanathan S; Ryan DE; Curry B; Lucas AB; Camarena J; Kaushik M; Hay SR; Martin RM; Steinfeld I; Bak RO; Dever DP; Hendel A; Bruhn L; Porteus MH
    Mol Ther; 2018 Oct; 26(10):2431-2442. PubMed ID: 30005866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells.
    Qu Q; Liu L; Chen G; Xu Y; Wu X; Wu D
    Cytotherapy; 2016 Mar; 18(3):452-64. PubMed ID: 26857234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and function of progenitor T cells from StemRegenin-1-expanded CD34+ human hematopoietic progenitor cells.
    Singh J; Chen ELY; Xing Y; Stefanski HE; Blazar BR; Zúñiga-Pflücker JC
    Blood Adv; 2019 Oct; 3(20):2934-2948. PubMed ID: 31648315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia.
    Tothova Z; Krill-Burger JM; Popova KD; Landers CC; Sievers QL; Yudovich D; Belizaire R; Aster JC; Morgan EA; Tsherniak A; Ebert BL
    Cell Stem Cell; 2017 Oct; 21(4):547-555.e8. PubMed ID: 28985529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.
    Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A
    Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells.
    Hoban MD; Romero Z; Cost GJ; Mendel M; Holmes M; Kohn DB
    Curr Protoc Stem Cell Biol; 2016 Feb; 36():5B.4.1-5B.4.10. PubMed ID: 26840227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells.
    Vavassori V; Ferrari S; Beretta S; Asperti C; Albano L; Annoni A; Gaddoni C; Varesi A; Soldi M; Cuomo A; Bonaldi T; Radrizzani M; Merelli I; Naldini L
    Blood; 2023 Aug; 142(9):812-826. PubMed ID: 37294917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bioactive Peptide SL-13R Expands Human Umbilical Cord Blood Hematopoietic Stem and Progenitor Cells In Vitro.
    Nii T; Konno K; Matsumoto M; Bhukhai K; Borwornpinyo S; Sakai K; Hongeng S; Sugiyama D
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
    Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
    Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.